nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Body temperature increased—Estropipate—osteoporosis	0.00136	0.00143	CcSEcCtD
Glycopyrrolate—Abdominal pain—Estropipate—osteoporosis	0.00136	0.00143	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ibandronate—osteoporosis	0.00136	0.00142	CcSEcCtD
Glycopyrrolate—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00136	0.00142	CcSEcCtD
Glycopyrrolate—Nervousness—Conjugated Estrogens—osteoporosis	0.00136	0.00142	CcSEcCtD
Glycopyrrolate—Infection—Risedronate—osteoporosis	0.00135	0.00142	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ibandronate—osteoporosis	0.00135	0.00141	CcSEcCtD
Glycopyrrolate—Urticaria—Alendronate—osteoporosis	0.00135	0.00141	CcSEcCtD
Glycopyrrolate—Epistaxis—Estradiol—osteoporosis	0.00135	0.00141	CcSEcCtD
Glycopyrrolate—Abdominal pain—Alendronate—osteoporosis	0.00134	0.0014	CcSEcCtD
Glycopyrrolate—Body temperature increased—Alendronate—osteoporosis	0.00134	0.0014	CcSEcCtD
Glycopyrrolate—Sinusitis—Estradiol—osteoporosis	0.00134	0.0014	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Risedronate—osteoporosis	0.00134	0.0014	CcSEcCtD
Glycopyrrolate—Agitation—Zoledronate—osteoporosis	0.00133	0.00139	CcSEcCtD
Glycopyrrolate—Skin disorder—Risedronate—osteoporosis	0.00132	0.00138	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Calcitriol—osteoporosis	0.00132	0.00138	CcSEcCtD
Glycopyrrolate—Abdominal pain—Raloxifene—osteoporosis	0.00132	0.00138	CcSEcCtD
Glycopyrrolate—Body temperature increased—Raloxifene—osteoporosis	0.00132	0.00138	CcSEcCtD
Glycopyrrolate—Vision blurred—Conjugated Estrogens—osteoporosis	0.00132	0.00138	CcSEcCtD
Glycopyrrolate—Urticaria—Ibandronate—osteoporosis	0.00131	0.00137	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ibandronate—osteoporosis	0.00131	0.00137	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ibandronate—osteoporosis	0.00131	0.00137	CcSEcCtD
Glycopyrrolate—Confusional state—Pamidronate—osteoporosis	0.00131	0.00137	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Pamidronate—osteoporosis	0.0013	0.00135	CcSEcCtD
Glycopyrrolate—Oedema—Pamidronate—osteoporosis	0.0013	0.00135	CcSEcCtD
Glycopyrrolate—Infection—Pamidronate—osteoporosis	0.00129	0.00135	CcSEcCtD
Glycopyrrolate—Rhinitis—Estradiol—osteoporosis	0.00129	0.00135	CcSEcCtD
Glycopyrrolate—Urticaria—Calcitriol—osteoporosis	0.00129	0.00134	CcSEcCtD
Glycopyrrolate—Palpitations—Zoledronate—osteoporosis	0.00128	0.00134	CcSEcCtD
Glycopyrrolate—Body temperature increased—Calcitriol—osteoporosis	0.00128	0.00134	CcSEcCtD
Glycopyrrolate—Abdominal pain—Calcitriol—osteoporosis	0.00128	0.00134	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Estradiol—osteoporosis	0.00128	0.00134	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Estropipate—osteoporosis	0.00127	0.00133	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Pamidronate—osteoporosis	0.00127	0.00133	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Estradiol—osteoporosis	0.00127	0.00133	CcSEcCtD
Glycopyrrolate—Vomiting—Etidronic acid—osteoporosis	0.00127	0.00133	CcSEcCtD
Glycopyrrolate—Tachycardia—Pamidronate—osteoporosis	0.00126	0.00132	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Estradiol—osteoporosis	0.00126	0.00132	CcSEcCtD
Glycopyrrolate—Urethral disorder—Estradiol—osteoporosis	0.00126	0.00132	CcSEcCtD
Glycopyrrolate—Rash—Etidronic acid—osteoporosis	0.00126	0.00131	CcSEcCtD
Glycopyrrolate—Convulsion—Zoledronate—osteoporosis	0.00126	0.00131	CcSEcCtD
Glycopyrrolate—Dermatitis—Etidronic acid—osteoporosis	0.00126	0.00131	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Pamidronate—osteoporosis	0.00125	0.00131	CcSEcCtD
Glycopyrrolate—Hypertension—Zoledronate—osteoporosis	0.00125	0.00131	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Alendronate—osteoporosis	0.00125	0.00131	CcSEcCtD
Glycopyrrolate—Headache—Etidronic acid—osteoporosis	0.00125	0.00131	CcSEcCtD
Glycopyrrolate—Asthenia—Estropipate—osteoporosis	0.00124	0.00129	CcSEcCtD
Glycopyrrolate—Palpitations—Conjugated Estrogens—osteoporosis	0.00123	0.00129	CcSEcCtD
Glycopyrrolate—Insomnia—Risedronate—osteoporosis	0.00123	0.00129	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00123	0.00128	CcSEcCtD
Glycopyrrolate—Pruritus—Estropipate—osteoporosis	0.00122	0.00128	CcSEcCtD
Glycopyrrolate—Asthenia—Alendronate—osteoporosis	0.00122	0.00127	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ibandronate—osteoporosis	0.00122	0.00127	CcSEcCtD
Glycopyrrolate—Hypotension—Pamidronate—osteoporosis	0.00121	0.00127	CcSEcCtD
Glycopyrrolate—Convulsion—Conjugated Estrogens—osteoporosis	0.00121	0.00126	CcSEcCtD
Glycopyrrolate—Dry mouth—Zoledronate—osteoporosis	0.00121	0.00126	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00121	0.00126	CcSEcCtD
Glycopyrrolate—Fatigue—Ethinyl Estradiol—osteoporosis	0.00121	0.00126	CcSEcCtD
Glycopyrrolate—Pruritus—Alendronate—osteoporosis	0.0012	0.00126	CcSEcCtD
Glycopyrrolate—Dyspepsia—Risedronate—osteoporosis	0.0012	0.00125	CcSEcCtD
Glycopyrrolate—Constipation—Ethinyl Estradiol—osteoporosis	0.0012	0.00125	CcSEcCtD
Glycopyrrolate—Confusional state—Zoledronate—osteoporosis	0.00119	0.00125	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Calcitriol—osteoporosis	0.00119	0.00125	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Estradiol—osteoporosis	0.00119	0.00125	CcSEcCtD
Glycopyrrolate—Flushing—Estradiol—osteoporosis	0.00119	0.00125	CcSEcCtD
Glycopyrrolate—Asthenia—Ibandronate—osteoporosis	0.00119	0.00124	CcSEcCtD
Glycopyrrolate—Nausea—Etidronic acid—osteoporosis	0.00118	0.00124	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Zoledronate—osteoporosis	0.00118	0.00124	CcSEcCtD
Glycopyrrolate—Oedema—Zoledronate—osteoporosis	0.00118	0.00124	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00118	0.00123	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Risedronate—osteoporosis	0.00118	0.00123	CcSEcCtD
Glycopyrrolate—Infection—Zoledronate—osteoporosis	0.00118	0.00123	CcSEcCtD
Glycopyrrolate—Fatigue—Risedronate—osteoporosis	0.00118	0.00123	CcSEcCtD
Glycopyrrolate—Insomnia—Pamidronate—osteoporosis	0.00117	0.00123	CcSEcCtD
Glycopyrrolate—Pruritus—Ibandronate—osteoporosis	0.00117	0.00122	CcSEcCtD
Glycopyrrolate—Pain—Risedronate—osteoporosis	0.00117	0.00122	CcSEcCtD
Glycopyrrolate—Constipation—Risedronate—osteoporosis	0.00117	0.00122	CcSEcCtD
Glycopyrrolate—Asthenia—Calcitriol—osteoporosis	0.00116	0.00121	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Zoledronate—osteoporosis	0.00116	0.00121	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Estradiol—osteoporosis	0.00116	0.00121	CcSEcCtD
Glycopyrrolate—Tachycardia—Zoledronate—osteoporosis	0.00116	0.00121	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00115	0.0012	CcSEcCtD
Glycopyrrolate—Somnolence—Pamidronate—osteoporosis	0.00115	0.0012	CcSEcCtD
Glycopyrrolate—Skin disorder—Zoledronate—osteoporosis	0.00115	0.0012	CcSEcCtD
Glycopyrrolate—Pruritus—Calcitriol—osteoporosis	0.00115	0.0012	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Zoledronate—osteoporosis	0.00114	0.0012	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00114	0.00119	CcSEcCtD
Glycopyrrolate—Dyspepsia—Pamidronate—osteoporosis	0.00114	0.00119	CcSEcCtD
Glycopyrrolate—Dizziness—Estropipate—osteoporosis	0.00114	0.00119	CcSEcCtD
Glycopyrrolate—Oedema—Conjugated Estrogens—osteoporosis	0.00114	0.00119	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00114	0.00119	CcSEcCtD
Glycopyrrolate—Infection—Conjugated Estrogens—osteoporosis	0.00113	0.00118	CcSEcCtD
Glycopyrrolate—Mental disorder—Estradiol—osteoporosis	0.00112	0.00118	CcSEcCtD
Glycopyrrolate—Dizziness—Alendronate—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Malnutrition—Estradiol—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Erythema—Estradiol—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Fatigue—Pamidronate—osteoporosis	0.00112	0.00117	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Risedronate—osteoporosis	0.00111	0.00117	CcSEcCtD
Glycopyrrolate—Tachycardia—Conjugated Estrogens—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Pain—Pamidronate—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Constipation—Pamidronate—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Skin disorder—Conjugated Estrogens—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Hypotension—Zoledronate—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00111	0.00116	CcSEcCtD
Glycopyrrolate—Dizziness—Raloxifene—osteoporosis	0.0011	0.00115	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0011	0.00115	CcSEcCtD
Glycopyrrolate—Flatulence—Estradiol—osteoporosis	0.0011	0.00115	CcSEcCtD
Glycopyrrolate—Tension—Estradiol—osteoporosis	0.0011	0.00115	CcSEcCtD
Glycopyrrolate—Vomiting—Estropipate—osteoporosis	0.0011	0.00115	CcSEcCtD
Glycopyrrolate—Dysgeusia—Estradiol—osteoporosis	0.00109	0.00114	CcSEcCtD
Glycopyrrolate—Dizziness—Ibandronate—osteoporosis	0.00109	0.00114	CcSEcCtD
Glycopyrrolate—Rash—Estropipate—osteoporosis	0.00109	0.00114	CcSEcCtD
Glycopyrrolate—Dermatitis—Estropipate—osteoporosis	0.00109	0.00114	CcSEcCtD
Glycopyrrolate—Nervousness—Estradiol—osteoporosis	0.00109	0.00113	CcSEcCtD
Glycopyrrolate—Urticaria—Risedronate—osteoporosis	0.00108	0.00113	CcSEcCtD
Glycopyrrolate—Headache—Estropipate—osteoporosis	0.00108	0.00113	CcSEcCtD
Glycopyrrolate—Vomiting—Alendronate—osteoporosis	0.00108	0.00113	CcSEcCtD
Glycopyrrolate—Body temperature increased—Risedronate—osteoporosis	0.00108	0.00113	CcSEcCtD
Glycopyrrolate—Abdominal pain—Risedronate—osteoporosis	0.00108	0.00113	CcSEcCtD
Glycopyrrolate—Rash—Alendronate—osteoporosis	0.00107	0.00112	CcSEcCtD
Glycopyrrolate—Insomnia—Zoledronate—osteoporosis	0.00107	0.00112	CcSEcCtD
Glycopyrrolate—Dermatitis—Alendronate—osteoporosis	0.00107	0.00112	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Pamidronate—osteoporosis	0.00107	0.00112	CcSEcCtD
Glycopyrrolate—Hypotension—Conjugated Estrogens—osteoporosis	0.00106	0.00111	CcSEcCtD
Glycopyrrolate—Headache—Alendronate—osteoporosis	0.00106	0.00111	CcSEcCtD
Glycopyrrolate—Vomiting—Raloxifene—osteoporosis	0.00106	0.00111	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Pamidronate—osteoporosis	0.00106	0.00111	CcSEcCtD
Glycopyrrolate—Rash—Raloxifene—osteoporosis	0.00105	0.0011	CcSEcCtD
Glycopyrrolate—Dermatitis—Raloxifene—osteoporosis	0.00105	0.0011	CcSEcCtD
Glycopyrrolate—Somnolence—Zoledronate—osteoporosis	0.00105	0.0011	CcSEcCtD
Glycopyrrolate—Vomiting—Ibandronate—osteoporosis	0.00105	0.0011	CcSEcCtD
Glycopyrrolate—Headache—Raloxifene—osteoporosis	0.00105	0.00109	CcSEcCtD
Glycopyrrolate—Rash—Ibandronate—osteoporosis	0.00104	0.00109	CcSEcCtD
Glycopyrrolate—Dermatitis—Ibandronate—osteoporosis	0.00104	0.00109	CcSEcCtD
Glycopyrrolate—Dyspepsia—Zoledronate—osteoporosis	0.00104	0.00109	CcSEcCtD
Glycopyrrolate—Headache—Ibandronate—osteoporosis	0.00104	0.00108	CcSEcCtD
Glycopyrrolate—Insomnia—Conjugated Estrogens—osteoporosis	0.00103	0.00108	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00103	0.00108	CcSEcCtD
Glycopyrrolate—Vomiting—Calcitriol—osteoporosis	0.00103	0.00108	CcSEcCtD
Glycopyrrolate—Agitation—Estradiol—osteoporosis	0.00103	0.00107	CcSEcCtD
Glycopyrrolate—Nausea—Estropipate—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Abdominal pain—Pamidronate—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Body temperature increased—Pamidronate—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Rash—Calcitriol—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Fatigue—Zoledronate—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Dermatitis—Calcitriol—osteoporosis	0.00102	0.00107	CcSEcCtD
Glycopyrrolate—Headache—Calcitriol—osteoporosis	0.00101	0.00106	CcSEcCtD
Glycopyrrolate—Somnolence—Conjugated Estrogens—osteoporosis	0.00101	0.00106	CcSEcCtD
Glycopyrrolate—Constipation—Zoledronate—osteoporosis	0.00101	0.00106	CcSEcCtD
Glycopyrrolate—Pain—Zoledronate—osteoporosis	0.00101	0.00106	CcSEcCtD
Glycopyrrolate—Nausea—Alendronate—osteoporosis	0.00101	0.00105	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Risedronate—osteoporosis	0.001	0.00105	CcSEcCtD
Glycopyrrolate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.001	0.00105	CcSEcCtD
Glycopyrrolate—Asthenia—Ethinyl Estradiol—osteoporosis	0.001	0.00105	CcSEcCtD
Glycopyrrolate—Nausea—Raloxifene—osteoporosis	0.000992	0.00104	CcSEcCtD
Glycopyrrolate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000989	0.00103	CcSEcCtD
Glycopyrrolate—Palpitations—Estradiol—osteoporosis	0.000988	0.00103	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000984	0.00103	CcSEcCtD
Glycopyrrolate—Fatigue—Conjugated Estrogens—osteoporosis	0.000983	0.00103	CcSEcCtD
Glycopyrrolate—Nausea—Ibandronate—osteoporosis	0.000982	0.00103	CcSEcCtD
Glycopyrrolate—Asthenia—Risedronate—osteoporosis	0.000978	0.00102	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Zoledronate—osteoporosis	0.000975	0.00102	CcSEcCtD
Glycopyrrolate—Constipation—Conjugated Estrogens—osteoporosis	0.000975	0.00102	CcSEcCtD
Glycopyrrolate—Pain—Conjugated Estrogens—osteoporosis	0.000975	0.00102	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Zoledronate—osteoporosis	0.000968	0.00101	CcSEcCtD
Glycopyrrolate—Hypertension—Estradiol—osteoporosis	0.000965	0.00101	CcSEcCtD
Glycopyrrolate—Pruritus—Risedronate—osteoporosis	0.000964	0.00101	CcSEcCtD
Glycopyrrolate—Nausea—Calcitriol—osteoporosis	0.000962	0.00101	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Pamidronate—osteoporosis	0.000955	0.000998	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000945	0.000988	CcSEcCtD
Glycopyrrolate—Urticaria—Zoledronate—osteoporosis	0.00094	0.000983	CcSEcCtD
Glycopyrrolate—Abdominal pain—Zoledronate—osteoporosis	0.000936	0.000978	CcSEcCtD
Glycopyrrolate—Body temperature increased—Zoledronate—osteoporosis	0.000936	0.000978	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000932	0.000974	CcSEcCtD
Glycopyrrolate—Dry mouth—Estradiol—osteoporosis	0.00093	0.000973	CcSEcCtD
Glycopyrrolate—Asthenia—Pamidronate—osteoporosis	0.00093	0.000972	CcSEcCtD
Glycopyrrolate—Dizziness—Ethinyl Estradiol—osteoporosis	0.000924	0.000966	CcSEcCtD
Glycopyrrolate—Confusional state—Estradiol—osteoporosis	0.00092	0.000961	CcSEcCtD
Glycopyrrolate—Pruritus—Pamidronate—osteoporosis	0.000917	0.000958	CcSEcCtD
Glycopyrrolate—Oedema—Estradiol—osteoporosis	0.000912	0.000953	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Estradiol—osteoporosis	0.000912	0.000953	CcSEcCtD
Glycopyrrolate—Infection—Estradiol—osteoporosis	0.000906	0.000947	CcSEcCtD
Glycopyrrolate—Urticaria—Conjugated Estrogens—osteoporosis	0.000905	0.000946	CcSEcCtD
Glycopyrrolate—Dizziness—Risedronate—osteoporosis	0.000901	0.000942	CcSEcCtD
Glycopyrrolate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000901	0.000942	CcSEcCtD
Glycopyrrolate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000901	0.000942	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Estradiol—osteoporosis	0.000894	0.000935	CcSEcCtD
Glycopyrrolate—Tachycardia—Estradiol—osteoporosis	0.00089	0.000931	CcSEcCtD
Glycopyrrolate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000889	0.000929	CcSEcCtD
Glycopyrrolate—Skin disorder—Estradiol—osteoporosis	0.000886	0.000926	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Estradiol—osteoporosis	0.000882	0.000922	CcSEcCtD
Glycopyrrolate—Rash—Ethinyl Estradiol—osteoporosis	0.000881	0.000921	CcSEcCtD
Glycopyrrolate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000881	0.000921	CcSEcCtD
Glycopyrrolate—Headache—Ethinyl Estradiol—osteoporosis	0.000876	0.000915	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Zoledronate—osteoporosis	0.000872	0.000912	CcSEcCtD
Glycopyrrolate—Vomiting—Risedronate—osteoporosis	0.000867	0.000906	CcSEcCtD
Glycopyrrolate—Rash—Risedronate—osteoporosis	0.000859	0.000898	CcSEcCtD
Glycopyrrolate—Dermatitis—Risedronate—osteoporosis	0.000859	0.000898	CcSEcCtD
Glycopyrrolate—Dizziness—Pamidronate—osteoporosis	0.000857	0.000896	CcSEcCtD
Glycopyrrolate—Headache—Risedronate—osteoporosis	0.000854	0.000893	CcSEcCtD
Glycopyrrolate—Asthenia—Zoledronate—osteoporosis	0.000849	0.000888	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00084	0.000878	CcSEcCtD
Glycopyrrolate—Pruritus—Zoledronate—osteoporosis	0.000837	0.000875	CcSEcCtD
Glycopyrrolate—Nausea—Ethinyl Estradiol—osteoporosis	0.00083	0.000868	CcSEcCtD
Glycopyrrolate—Insomnia—Estradiol—osteoporosis	0.000825	0.000862	CcSEcCtD
Glycopyrrolate—Vomiting—Pamidronate—osteoporosis	0.000824	0.000861	CcSEcCtD
Glycopyrrolate—Asthenia—Conjugated Estrogens—osteoporosis	0.000818	0.000855	CcSEcCtD
Glycopyrrolate—Rash—Pamidronate—osteoporosis	0.000817	0.000854	CcSEcCtD
Glycopyrrolate—Dermatitis—Pamidronate—osteoporosis	0.000816	0.000853	CcSEcCtD
Glycopyrrolate—Headache—Pamidronate—osteoporosis	0.000812	0.000849	CcSEcCtD
Glycopyrrolate—Somnolence—Estradiol—osteoporosis	0.000811	0.000848	CcSEcCtD
Glycopyrrolate—Nausea—Risedronate—osteoporosis	0.00081	0.000846	CcSEcCtD
Glycopyrrolate—Pruritus—Conjugated Estrogens—osteoporosis	0.000806	0.000843	CcSEcCtD
Glycopyrrolate—Dyspepsia—Estradiol—osteoporosis	0.000803	0.000839	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Estradiol—osteoporosis	0.000787	0.000823	CcSEcCtD
Glycopyrrolate—Fatigue—Estradiol—osteoporosis	0.000786	0.000822	CcSEcCtD
Glycopyrrolate—Dizziness—Zoledronate—osteoporosis	0.000783	0.000818	CcSEcCtD
Glycopyrrolate—Pain—Estradiol—osteoporosis	0.00078	0.000815	CcSEcCtD
Glycopyrrolate—Constipation—Estradiol—osteoporosis	0.00078	0.000815	CcSEcCtD
Glycopyrrolate—Nausea—Pamidronate—osteoporosis	0.00077	0.000805	CcSEcCtD
Glycopyrrolate—Dizziness—Conjugated Estrogens—osteoporosis	0.000754	0.000788	CcSEcCtD
Glycopyrrolate—Vomiting—Zoledronate—osteoporosis	0.000753	0.000787	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Estradiol—osteoporosis	0.000752	0.000786	CcSEcCtD
Glycopyrrolate—Rash—Zoledronate—osteoporosis	0.000746	0.00078	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Estradiol—osteoporosis	0.000746	0.00078	CcSEcCtD
Glycopyrrolate—Dermatitis—Zoledronate—osteoporosis	0.000746	0.000779	CcSEcCtD
Glycopyrrolate—Headache—Zoledronate—osteoporosis	0.000741	0.000775	CcSEcCtD
Glycopyrrolate—Vomiting—Conjugated Estrogens—osteoporosis	0.000725	0.000757	CcSEcCtD
Glycopyrrolate—Urticaria—Estradiol—osteoporosis	0.000725	0.000757	CcSEcCtD
Glycopyrrolate—Abdominal pain—Estradiol—osteoporosis	0.000721	0.000754	CcSEcCtD
Glycopyrrolate—Body temperature increased—Estradiol—osteoporosis	0.000721	0.000754	CcSEcCtD
Glycopyrrolate—Rash—Conjugated Estrogens—osteoporosis	0.000719	0.000751	CcSEcCtD
Glycopyrrolate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000718	0.00075	CcSEcCtD
Glycopyrrolate—Headache—Conjugated Estrogens—osteoporosis	0.000714	0.000746	CcSEcCtD
Glycopyrrolate—Nausea—Zoledronate—osteoporosis	0.000703	0.000735	CcSEcCtD
Glycopyrrolate—Nausea—Conjugated Estrogens—osteoporosis	0.000677	0.000708	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Estradiol—osteoporosis	0.000672	0.000702	CcSEcCtD
Glycopyrrolate—Asthenia—Estradiol—osteoporosis	0.000654	0.000684	CcSEcCtD
Glycopyrrolate—Pruritus—Estradiol—osteoporosis	0.000645	0.000675	CcSEcCtD
Glycopyrrolate—Dizziness—Estradiol—osteoporosis	0.000603	0.00063	CcSEcCtD
Glycopyrrolate—Vomiting—Estradiol—osteoporosis	0.00058	0.000606	CcSEcCtD
Glycopyrrolate—Rash—Estradiol—osteoporosis	0.000575	0.000601	CcSEcCtD
Glycopyrrolate—Dermatitis—Estradiol—osteoporosis	0.000575	0.000601	CcSEcCtD
Glycopyrrolate—Headache—Estradiol—osteoporosis	0.000571	0.000597	CcSEcCtD
Glycopyrrolate—Nausea—Estradiol—osteoporosis	0.000542	0.000566	CcSEcCtD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CALCA—osteoporosis	8.34e-05	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LRP6—osteoporosis	8.29e-05	0.00191	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PTHLH—osteoporosis	8.24e-05	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CALCA—osteoporosis	7.99e-05	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CALCR—osteoporosis	7.87e-05	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTH1R—osteoporosis	7.87e-05	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CALCR—osteoporosis	7.85e-05	0.00181	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTH1R—osteoporosis	7.85e-05	0.00181	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CALCR—osteoporosis	7.77e-05	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTH1R—osteoporosis	7.77e-05	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—POMC—osteoporosis	7.72e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PTH—osteoporosis	7.71e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PTH—osteoporosis	7.69e-05	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—OXCT1—osteoporosis	7.65e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CA2—osteoporosis	7.65e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PTH—osteoporosis	7.61e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CALCA—osteoporosis	7.58e-05	0.00175	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	7.51e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	7.49e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MGLL—osteoporosis	7.46e-05	0.00172	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	7.42e-05	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—POMC—osteoporosis	7.4e-05	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TLN1—osteoporosis	7.31e-05	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CALCA—osteoporosis	7.26e-05	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TLN1—osteoporosis	7e-05	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTH—osteoporosis	7e-05	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTH—osteoporosis	6.98e-05	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTH—osteoporosis	6.91e-05	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.84e-05	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CNR2—osteoporosis	6.82e-05	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.82e-05	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CNR2—osteoporosis	6.8e-05	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.75e-05	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CNR2—osteoporosis	6.74e-05	0.00155	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—WNT1—osteoporosis	6.42e-05	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—WNT1—osteoporosis	6.4e-05	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	6.39e-05	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	6.37e-05	0.00147	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	6.35e-05	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—IDH2—osteoporosis	6.34e-05	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—WNT1—osteoporosis	6.33e-05	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	6.31e-05	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—P4HB—osteoporosis	6.31e-05	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MGLL—osteoporosis	6.26e-05	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MGLL—osteoporosis	6.24e-05	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MGLL—osteoporosis	6.18e-05	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTH—osteoporosis	6.13e-05	0.00141	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LRP5—osteoporosis	6.11e-05	0.00141	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LRP5—osteoporosis	6.09e-05	0.0014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—P4HB—osteoporosis	6.04e-05	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAP1A—osteoporosis	6.03e-05	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LRP5—osteoporosis	6.03e-05	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CNR2—osteoporosis	5.98e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP27A1—osteoporosis	5.96e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—ADCY5—osteoporosis	5.93e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NFATC1—osteoporosis	5.88e-05	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTH—osteoporosis	5.87e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LRP6—osteoporosis	5.84e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—DKK1—osteoporosis	5.84e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LRP6—osteoporosis	5.82e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	5.8e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ACP5—osteoporosis	5.8e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	5.78e-05	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAP1A—osteoporosis	5.77e-05	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LRP6—osteoporosis	5.77e-05	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	5.73e-05	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CNR2—osteoporosis	5.73e-05	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.7e-05	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	5.68e-05	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NFATC1—osteoporosis	5.63e-05	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	5.63e-05	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—WNT1—osteoporosis	5.62e-05	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	5.61e-05	0.00129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—DKK1—osteoporosis	5.59e-05	0.00129	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	5.55e-05	0.00128	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGA—osteoporosis	5.47e-05	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TPI1—osteoporosis	5.39e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—ADCY5—osteoporosis	5.39e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—WNT1—osteoporosis	5.38e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGA—osteoporosis	5.24e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—POMC—osteoporosis	5.21e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—POMC—osteoporosis	5.19e-05	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	5.16e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—POMC—osteoporosis	5.14e-05	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	5.12e-05	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CALCA—osteoporosis	5.11e-05	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CALCA—osteoporosis	5.09e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTHLH—osteoporosis	5.08e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—BMP2—osteoporosis	5.08e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—P4HB—osteoporosis	5.07e-05	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CALCA—osteoporosis	5.04e-05	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GAPDH—osteoporosis	4.98e-05	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGB—osteoporosis	4.97e-05	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TLN1—osteoporosis	4.93e-05	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TLN1—osteoporosis	4.92e-05	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTHLH—osteoporosis	4.87e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—BMP2—osteoporosis	4.87e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TLN1—osteoporosis	4.87e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—RAP1A—osteoporosis	4.85e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PSMA2—osteoporosis	4.8e-05	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PSMA5—osteoporosis	4.8e-05	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGB—osteoporosis	4.76e-05	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PSMA2—osteoporosis	4.6e-05	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PSMA5—osteoporosis	4.6e-05	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CALCA—osteoporosis	4.48e-05	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—POMC—osteoporosis	4.36e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CALCA—osteoporosis	4.29e-05	0.000988	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—P4HB—osteoporosis	4.25e-05	0.000981	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—P4HB—osteoporosis	4.24e-05	0.000977	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—osteoporosis	4.24e-05	0.000977	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—P4HB—osteoporosis	4.2e-05	0.000968	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—POMC—osteoporosis	4.18e-05	0.000964	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTH—osteoporosis	4.14e-05	0.000954	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTH—osteoporosis	4.12e-05	0.000951	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTH—osteoporosis	4.08e-05	0.000942	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAP1A—osteoporosis	4.07e-05	0.000937	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KL—osteoporosis	4.06e-05	0.000937	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAP1A—osteoporosis	4.05e-05	0.000934	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CNR2—osteoporosis	4.03e-05	0.00093	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CNR2—osteoporosis	4.02e-05	0.000927	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.01e-05	0.000925	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAP1A—osteoporosis	4.01e-05	0.000925	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	4e-05	0.000923	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4e-05	0.000923	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	3.99e-05	0.00092	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CNR2—osteoporosis	3.98e-05	0.000918	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFATC1—osteoporosis	3.97e-05	0.000915	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—POMC—osteoporosis	3.96e-05	0.000914	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFATC1—osteoporosis	3.95e-05	0.000912	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	3.95e-05	0.000911	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DKK1—osteoporosis	3.93e-05	0.000907	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DKK1—osteoporosis	3.92e-05	0.000904	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ENO1—osteoporosis	3.92e-05	0.000903	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFATC1—osteoporosis	3.91e-05	0.000903	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KL—osteoporosis	3.89e-05	0.000897	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DKK1—osteoporosis	3.88e-05	0.000896	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6R—osteoporosis	3.87e-05	0.000892	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PSMA5—osteoporosis	3.86e-05	0.00089	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PSMA2—osteoporosis	3.86e-05	0.00089	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—POMC—osteoporosis	3.8e-05	0.000875	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—WNT1—osteoporosis	3.79e-05	0.000874	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—WNT1—osteoporosis	3.78e-05	0.000871	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—WNT1—osteoporosis	3.74e-05	0.000863	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6R—osteoporosis	3.7e-05	0.000854	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGA—osteoporosis	3.69e-05	0.00085	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGA—osteoporosis	3.68e-05	0.000847	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGA—osteoporosis	3.64e-05	0.000839	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	3.63e-05	0.000838	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	3.62e-05	0.000835	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	3.59e-05	0.000827	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTHLH—osteoporosis	3.43e-05	0.00079	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BMP2—osteoporosis	3.43e-05	0.00079	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BMP2—osteoporosis	3.42e-05	0.000788	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTHLH—osteoporosis	3.42e-05	0.000788	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTHLH—osteoporosis	3.38e-05	0.00078	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BMP2—osteoporosis	3.38e-05	0.00078	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGB—osteoporosis	3.35e-05	0.000773	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGB—osteoporosis	3.34e-05	0.000771	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGB—osteoporosis	3.31e-05	0.000764	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PSMA2—osteoporosis	3.24e-05	0.000747	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PSMA5—osteoporosis	3.24e-05	0.000747	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PSMA2—osteoporosis	3.23e-05	0.000744	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PSMA5—osteoporosis	3.23e-05	0.000744	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PSMA2—osteoporosis	3.2e-05	0.000737	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PSMA5—osteoporosis	3.2e-05	0.000737	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ADCY5—osteoporosis	3.18e-05	0.000734	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP19A1—osteoporosis	3.13e-05	0.000722	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SPP1—osteoporosis	3.08e-05	0.00071	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADCY5—osteoporosis	3.05e-05	0.000703	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CALCA—osteoporosis	3.02e-05	0.000696	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CALCA—osteoporosis	3.01e-05	0.000694	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CALCA—osteoporosis	2.98e-05	0.000687	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SPP1—osteoporosis	2.95e-05	0.00068	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—POMC—osteoporosis	2.94e-05	0.000679	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—POMC—osteoporosis	2.93e-05	0.000677	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—POMC—osteoporosis	2.91e-05	0.00067	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IRS2—osteoporosis	2.79e-05	0.000642	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KL—osteoporosis	2.74e-05	0.000632	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KL—osteoporosis	2.73e-05	0.00063	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LEP—osteoporosis	2.73e-05	0.000629	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KL—osteoporosis	2.7e-05	0.000624	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—POMC—osteoporosis	2.67e-05	0.000616	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IRS2—osteoporosis	2.67e-05	0.000615	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—POMC—osteoporosis	2.66e-05	0.000614	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—POMC—osteoporosis	2.64e-05	0.000608	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LEP—osteoporosis	2.61e-05	0.000602	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6R—osteoporosis	2.61e-05	0.000601	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ESR1—osteoporosis	2.6e-05	0.0006	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6R—osteoporosis	2.6e-05	0.000599	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6R—osteoporosis	2.57e-05	0.000593	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ADCY5—osteoporosis	2.56e-05	0.00059	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX1—osteoporosis	2.55e-05	0.000588	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ESR1—osteoporosis	2.49e-05	0.000575	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IRS1—osteoporosis	2.43e-05	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—osteoporosis	2.35e-05	0.000543	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—POMC—osteoporosis	2.34e-05	0.00054	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IRS1—osteoporosis	2.33e-05	0.000537	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6R—osteoporosis	2.28e-05	0.000527	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IGF1—osteoporosis	2.25e-05	0.000519	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—POMC—osteoporosis	2.24e-05	0.000517	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6R—osteoporosis	2.19e-05	0.000504	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1—osteoporosis	2.16e-05	0.000497	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADCY5—osteoporosis	2.15e-05	0.000495	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADCY5—osteoporosis	2.14e-05	0.000493	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADCY5—osteoporosis	2.12e-05	0.000489	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—osteoporosis	2.08e-05	0.000479	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—osteoporosis	2.07e-05	0.000477	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—osteoporosis	2.05e-05	0.000473	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—POMC—osteoporosis	1.88e-05	0.000434	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.88e-05	0.000433	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.000432	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.85e-05	0.000427	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—osteoporosis	1.84e-05	0.000424	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.000422	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—osteoporosis	1.81e-05	0.000418	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.75e-05	0.000405	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.75e-05	0.000403	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.73e-05	0.000399	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.72e-05	0.000397	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.65e-05	0.00038	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.64e-05	0.000378	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.62e-05	0.000373	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—POMC—osteoporosis	1.58e-05	0.000364	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—POMC—osteoporosis	1.57e-05	0.000363	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—POMC—osteoporosis	1.56e-05	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.54e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.54e-05	0.000354	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.52e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.52e-05	0.00035	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.51e-05	0.000349	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.5e-05	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—osteoporosis	1.35e-05	0.000312	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—osteoporosis	1.35e-05	0.000311	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—osteoporosis	1.3e-05	0.000299	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—osteoporosis	1.29e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—osteoporosis	1.16e-05	0.000268	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—osteoporosis	1.16e-05	0.000267	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.15e-05	0.000264	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—osteoporosis	1.02e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—osteoporosis	9.74e-06	0.000225	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—osteoporosis	9.13e-06	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—osteoporosis	9.1e-06	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—osteoporosis	9.1e-06	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—osteoporosis	9.08e-06	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—osteoporosis	9.01e-06	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—osteoporosis	8.99e-06	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—osteoporosis	6.86e-06	0.000158	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—osteoporosis	6.84e-06	0.000158	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—osteoporosis	6.77e-06	0.000156	CbGpPWpGaD
